Preventing or delaying the onset of end-stage kidney disease is vital. By implementing a results-driven, value-based approach ...
The new Ochsner site will contribute to uncovering additional genes as well as examine health disparities and care access for ...
PM8002/BNT327 plus nab-paclitaxel demonstrated “clinically meaningful” activity in advanced TNBC, according to researchers.
Wearable sensor data combined with machine learning predicts fall risk in Parkinson's patients, enhancing preventive care and ...
Merck MRK announced that its phase III KEYLYNK-001 study, evaluating its blockbuster anti-PD-1 therapy Keytruda regimen in ...
A bispecifics can unseat Keytruda. | BioNTech reported an 18-month overall survival rate of 69.7%, beating the cross-trial ...
Researchers at the Foundation have uncovered new insights into the complex link between dopamine and rest tremor in Parkinson ...